ArticleIntestinal research2021

Efficacy and safety of vedolizumab in Crohn's disease in patients from Asian countries in the GEMINI 2 study.

Rupa Banerjee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.